The development of a dedicated leadership team was identified as a pivotal priority in the Cancer Center strategic planning process to ensure consultative, transparent and effective decision-making. This was accomplished in the last project period through a combination of new appointments, creation of new leadership positions in the Cancer Center and reconfiguration of existing roles for optimal impact on the cancer research agenda. As part of this reorganization. Dr. Rauscher was appointed as a the sole Deputy Director of the Cancer Center with a codified succession plan should the need arise to replace the current Director, and a second Deputy Director position that was previously filled by Dr. Herlyn was eliminated. Since the introduction of these changes, the senior leadership team has worked well together, guiding an extensive and transparent consultative process that involved every administrative, scientific and educational segment ofthe Cancer Center, and leading a stepwise but decisive implementation ofthe ensuing strategic directives. Together, the senior leaders prioritized changes in the scientific alignment of Programs and Shared Resources, directed an aggressive and successful faculty recruitment effort that brought to the Cancer Center seven new faculty members appointed at all academic ranks, refocused administrative functions and decision-making processes, identified opportunities for translational and patient-oriented cancer research and developed new initiatives to expand education and mentoring, including for underrepresented minorities. Overall, the senior leadership team has catalyzed the introduction of a productive culture of collaboration and scientific exchange that has transformed the Cancer Center in the last budget period, bringing about expansive gains in NCI and cancer-related funding, and significant increase in collaborative, joint publications across the three Cancer Center Programs. This positive trajectory will continue in the next budget period, when the leadership team will guide the largest faculty and facility expansion of the Cancer Center in forty years enabled by the opening of the new Wistar Research Tower

Public Health Relevance

The newly configured Cancer Center leadership team has successfully leveraged a lean, opportunity-driven administrative infrastructure to bring about expansive gains in cancer focus, collaborative science, joint funding and innovative education to fulfill the vision of the Cancer Center of conquering cancer through outstanding research, education and partnership.

National Institute of Health (NIH)
National Cancer Institute (NCI)
Center Core Grants (P30)
Project #
Application #
Study Section
Subcommittee G - Education (NCI)
Project Start
Project End
Budget Start
Budget End
Support Year
Fiscal Year
Total Cost
Indirect Cost
Wistar Institute
United States
Zip Code
Qin, Jie; Rajaratnam, Rajathees; Feng, Li et al. (2015) Development of organometallic S6K1 inhibitors. J Med Chem 58:305-14
Tomescu, Costin; Seaton, Kelly E; Smith, Peter et al. (2015) Innate activation of MDC and NK cells in high-risk HIV-1-exposed seronegative IV-drug users who share needles when compared with low-risk nonsharing IV-drug user controls. J Acquir Immune Defic Syndr 68:264-73
Gekonge, Bethsebah; Bardin, Matthew C; Montaner, Luis J (2015) Short communication: Nitazoxanide inhibits HIV viral replication in monocyte-derived macrophages. AIDS Res Hum Retroviruses 31:237-41
Webster, Marie R; Xu, Mai; Kinzler, Kathryn A et al. (2015) Wnt5A promotes an adaptive, senescent-like stress response, while continuing to drive invasion in melanoma cells. Pigment Cell Melanoma Res 28:184-95
Zhang, Xuhui; Akech, Jacqueline; Browne, Gillian et al. (2015) Runx2-Smad signaling impacts the progression of tumor-induced bone disease. Int J Cancer 136:1321-32
Kung, Che-Pei; Khaku, Sakina; Jennis, Matthew et al. (2015) Identification of TRIML2, a novel p53 target, that enhances p53 SUMOylation and regulates the transactivation of proapoptotic genes. Mol Cancer Res 13:250-62
Gumireddy, Kiranmai; Li, Anping; Kossenkov, Andrew V et al. (2014) ID1 promotes breast cancer metastasis by S100A9 regulation. Mol Cancer Res 12:1334-43
Wolf, Amaya I; Strauman, Maura C; Mozdzanowska, Krystyna et al. (2014) Pneumolysin expression by streptococcus pneumoniae protects colonized mice from influenza virus-induced disease. Virology 462-463:254-65
Newhart, Alyshia; Janicki, Susan M (2014) Seeing is believing: visualizing transcriptional dynamics in single cells. J Cell Physiol 229:259-65
Budina-Kolomets, Anna; Balaburski, Gregor M; Bondar, Anastasia et al. (2014) Comparison of the activity of three different HSP70 inhibitors on apoptosis, cell cycle arrest, autophagy inhibition, and HSP90 inhibition. Cancer Biol Ther 15:194-9

Showing the most recent 10 out of 182 publications